Sarah Di Troia Joins Workwonder as Partner

1/26/21

Sarah Di Troia

Sarah DiTroia joins the executive coaching, non-profit consulting and fundraising strategy consultancy, Workwonder as Partner according to DeTemple who is President of the firm. Di Troia will focus on helping leaders create organizational strategies that achieve breakthrough impact and financial sustainability.

Previously, Di Troia spent four years as Chief Operating Officer of Health Leads where she led the doubling of impact, developed new earned revenue streams, and positioned Health Leads for a successful $30 million capital raise to fuel new growth. Prior to Health Leads, Di Troia was Managing Partner at New Profit and worked as an Associate Director at The Center for Effective Philanthropy (CEP), a nonprofit dedicated to assessing and improving the overall performance of philanthropic foundations. Before her role at CEP, she was a Principal at Axxon Capital, a fund focused on exploring the market opportunity in the deficit of equity investments in women and minority-led companies. All are located in Boston.

DeTemple comments, “Her 30 years of experience as a grantmaker, strategic advisor and nonprofit executive fuels an approach that integrates market and stakeholder insights with the pragmatic business operations necessary to realize new opportunities. Vetting market opportunities and business models are recurrent themes over the course of Sarah’s career. As a for-profit and nonprofit investor/grantmaker she has reviewed over a thousand business models developing strong pattern recognition for success.“

Di Troia graduated cum laude from Dartmouth College and went on to earn a Master’s Degree in Business Administration from Harvard Business School.

Current clients include Year Up, Project Evident, Eye to Eye, New Profit and Ashoka among others.

Workwonder is based in Boston, for additional information and an invitation for a virtual coffee, please go to: www.workwonder.today.

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.